Your browser doesn't support javascript.
loading
Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever.
Hartley, M Gill; Norville, Isobel H; Richards, Mark I; Barnes, Kay B; Bewley, Kevin R; Vipond, Julia; Rayner, Emma; Vente, Andreas; Armstrong, Stuart J; Harding, Sarah V.
Afiliação
  • Hartley MG; CBR Division, Defence Science and Technology Laboratory (Dstl), Porton Down, Salisbury, United Kingdom.
  • Norville IH; CBR Division, Defence Science and Technology Laboratory (Dstl), Porton Down, Salisbury, United Kingdom.
  • Richards MI; College of Life and Environmental Sciences, University of Exeter, Exeter, United Kingdom.
  • Barnes KB; CBR Division, Defence Science and Technology Laboratory (Dstl), Porton Down, Salisbury, United Kingdom.
  • Bewley KR; CBR Division, Defence Science and Technology Laboratory (Dstl), Porton Down, Salisbury, United Kingdom.
  • Vipond J; Public Health England, Porton Down, Salisbury, United Kingdom.
  • Rayner E; Public Health England, Porton Down, Salisbury, United Kingdom.
  • Vente A; Public Health England, Porton Down, Salisbury, United Kingdom.
  • Armstrong SJ; MerLion Pharmaceuticals, Berlin, Germany.
  • Harding SV; CBR Division, Defence Science and Technology Laboratory (Dstl), Porton Down, Salisbury, United Kingdom.
Front Microbiol ; 12: 760698, 2021.
Article em En | MEDLINE | ID: mdl-34917048
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article